• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sanofi appoints two new members to executive committee

Sanofi appoints two new members to executive committee

May 3, 2013
CenterWatch Staff

Global healthcare company Sanofi is creating two new units, global commercial operations and global divisions and strategic commercial development, to replace the former global operations unit. Peter Guenter, currently senior vice president, Europe, will be appointed executive vice president of global commercial operations. Pascale Witz, currently president and CEO of medical diagnostics at GE Healthcare, will join Sanofi as executive vice president of global divisions and strategic commercial development. Both Guenter and Witz will join the executive committee.

As executive vice president of global commercial operations, Guenterwill focus on in-market execution across the diverse regions of North America, Latin America, Europe, Asia, Japan and Pacific and Intercontinental. He brings more than 25 years of experience in the pharmaceutical industry. Peter joined the Group in 1995 and held various senior positions in Belgium, France, Europe and global marketing, including  general manager, Belgium; vice president for Eastern Europe; vice president, Northern Europe; general manager of commercial operations for Germany; head of multi-country organization for Germany, Austria and Switzerland.

Guenter started his career as a sales representative for SmithKline in 1986, and held a number of positions in marketing in Ciba Geigy and Parke Davis, before joining Sanofi in 1995 as business unit director CNS/urology in the Belgian affiliate.

As executive vice president of global divisions and strategic commercial development, Witz will be responsible for setting the strategic direction and guiding product development of the Group key businesses. She started her career in a research lab before moving to marketing at Becton Dickinson France in 1991. She joined GE Healthcare in 1996 as product manager for the vascular business in France. Over the years, Witz rose up through the company and developed a successful international career within GE in Europe, Africa, Middle East and the U.S. Prior to taking up the position of president and CEO of the medical diagnostics business, she was vice president and general manager for the global interventional business for France and U.S.

Throughout her career within GE, Witz headed up a number of businesses: she was general manager of computed tomography; vice president of sales and marketing services; general manager of nuclear medicine and PET; vice president of  IT and vice president of Six Sigma and quality.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing